They linked an indole-based HDAC8-selective inhibitor PCI-34051 with CRBN or VHL ligands and selected CRBN-based compound 16e (SZUH280) (48) with a short PEG linker as the effective HDAC8 degrader in the 549 human lung cancer cell line. The gene discussed is HDAC8; the disease is lung carcinoma.